News

NIR-II imaging and bioluminescence tomography on the Vivoptic platform

In partnership with Vilber, an imaging system enabling fluorescence imaging in NIR-II and bioluminescence tomography will be available on loan on the Vivoptic platform from 15/06 to 03/07.

Fluorescence imaging in NIR-II (1000–1700 nm) corresponds to the second imaging window. It offers several advantages: reduced autofluorescence, tissue scattering and absorption, as well as improved image resolution.

A system enabling bioluminescence tomography for firefly luciferase and nanoluciferase will also be available.

So if you are interested in these imaging modalities or would like to discover the technology in order to include it in your research projects, contact us to test your samples!

If there is strong interest in this technology, Vivoptic may acquire such an imaging system.

CRISP’edit

The CRISP’edit platform takes part in the CRISPRMED26 congress in Copenhagen

The CRISP’edit platform team attended the CRISPRMED26 congress in Copenhagen. On this occasion, Valérie Prouzet-Mauléon represented the platform during the “EU CRISPR Screening and Editing Facilities Forum” workshop, where she presented its activities and expertise.

UB’L3

International cooperation & research

In November, Marie-Line Andréola and Patricia Recordon-Pinson, from the UB’L3 platform, travelled to the University of Pernambuco in Recife, Brazil, as part of a mission funded by the University of Bordeaux through its internationalization programme.

This visit followed on from a scientific collaboration established two years ago with Brazilian researchers. It notably made it possible to assess the progress of the construction of a BSL-3 containment laboratory in Recife and to contribute to discussions on the layout of the facilities.

During their stay, they also took part in a workshop dedicated to virology practices and handling procedures in a BSL-3 laboratory.

This visit was also an opportunity to review and strengthen ongoing research projects between the two institutions, thereby reinforcing scientific and institutional links.

Vect’UB

VectUB expands its services: a new non-integrative transfer tool for the CRISPR-Cas9 system

TBMCore’s Vect’UB platform is expanding its service offer with the development of a new tool for safe gene editing. Camille Charbonnieras, assistant engineer, and Jennifer Cattiaux, research engineer within TBMCore, explain this new service.

Read the article

CRISP’edit